These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8188689)

  • 61. Expression of a functional human type I interferon receptor in hamster cells: application of functional yeast artificial chromosome (YAC) screening.
    Soh J; Mariano TM; Lim JK; Izotova L; Mirochnitchenko O; Schwartz B; Langer JA; Pestka S
    J Biol Chem; 1994 Jul; 269(27):18102-10. PubMed ID: 8027072
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA.
    McNair AN; Cheng D; Monjardino J; Thomas HC; Kerr IM
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1371-8. PubMed ID: 7911507
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties.
    Hardy MP; Owczarek CM; Trajanovska S; Liu X; Kola I; Hertzog PJ
    Blood; 2001 Jan; 97(2):473-82. PubMed ID: 11154225
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cloning, expression, purification, and biological activity of five feline type I interferons.
    Wonderling R; Powell T; Baldwin S; Morales T; Snyder S; Keiser K; Hunter S; Best E; McDermott MJ; Milhausen M
    Vet Immunol Immunopathol; 2002 Oct; 89(1-2):13-27. PubMed ID: 12208047
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human interferons alpha, beta and omega.
    Bekisz J; Schmeisser H; Hernandez J; Goldman ND; Zoon KC
    Growth Factors; 2004 Dec; 22(4):243-51. PubMed ID: 15621727
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interferon-Inducible Oligoadenylate Synthetase-Like Protein Acts as an Antiviral Effector against Classical Swine Fever Virus via the MDA5-Mediated Type I Interferon-Signaling Pathway.
    Li LF; Yu J; Zhang Y; Yang Q; Li Y; Zhang L; Wang J; Li S; Luo Y; Sun Y; Qiu HJ
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331099
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells.
    Urin V; Shemesh M; Schreiber G
    J Mol Biol; 2019 Aug; 431(17):3324-3338. PubMed ID: 31207241
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Possible involvement of virus-induced protein kinase in the antiviral state induced with interferon-gamma against Sindbis virus.
    Saito S
    J Interferon Res; 1989 Feb; 9(1):23-34. PubMed ID: 2541209
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structure-function study of the extracellular domain of the human type I interferon receptor (IFNAR)-1 subunit.
    Kumaran J; Colamonici OR; Fish EN
    J Interferon Cytokine Res; 2000 May; 20(5):479-85. PubMed ID: 10841076
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Induction of 2',5'-oligoadenylate synthetase in freshly separated malignant cells from solid tumors. Variability in the susceptibility of interferon.
    Einhorn S; Vánky F; Grandér D; Willems JS
    Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1607-13. PubMed ID: 2448144
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity.
    Rosenblum MG; Yung WK; Kelleher PJ; Ruzicka F; Steck PA; Borden EC
    J Interferon Res; 1990 Apr; 10(2):141-51. PubMed ID: 2140395
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of three domains in the biological activity of human interferon-alpha.
    Fish EN; Banerjee K; Stebbing N
    J Interferon Res; 1989 Feb; 9(1):97-114. PubMed ID: 2523943
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Isoforms p69 and p100 of 2',5'-oligoadenylate synthetase induced differentially by interferons in vivo and in vitro.
    Witt PL; Marié I; Robert N; Irizarry A; Borden EC; Hovanessian AG
    J Interferon Res; 1993 Feb; 13(1):17-23. PubMed ID: 8454907
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells.
    Pogue SL; Preston BT; Stalder J; Bebbington CR; Cardarelli PM
    J Interferon Cytokine Res; 2004 Feb; 24(2):131-9. PubMed ID: 14980077
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Upregulation of type I interferon receptor by IFN-gamma.
    Mizukoshi E; Kaneko S; Yanagi M; Ohno H; Matsushita E; Kobayashi K
    J Interferon Cytokine Res; 1999 Sep; 19(9):1019-23. PubMed ID: 10505744
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Antiviral and antiproliferative activity of human interferons and their induction of 2',5'-oligoadenylate synthetase].
    Krispin TI; Itkes AV; Balandin IG; Solov'eva MF; Kuznetsov VP
    Mol Gen Mikrobiol Virusol; 1986 Apr; (4):42-6. PubMed ID: 2432419
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
    Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
    Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Basic study on human lymphoblastoid interferon-alpha (MOR-22): Part I. Antiviral effect].
    Nobuhara M; Kanamori T; Morishita H; Horisawa Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):122-6. PubMed ID: 3942393
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of functional type I and type II interferon receptors.
    Pestka S
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1301-19. PubMed ID: 7705745
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intracellular murine IFN-gamma mediates virus resistance, expression of oligoadenylate synthetase, and activation of STAT transcription factors.
    Will A; Hemmann U; Horn F; Röllinghoff M; Gessner A
    J Immunol; 1996 Nov; 157(10):4576-83. PubMed ID: 8906836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.